• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

口腔作为幽门螺杆菌导致胃部再次感染的潜在来源。

Oral cavity as a potential source of gastric reinfection by Helicobacter pylori.

作者信息

Karczewska Elzbieta, Konturek Joanna E, Konturek Peter C, Cześnikiewicz Marta, Sito Edward, Bielański Władysław, Kwiecień Nina, Obtułowicz Wojciech, Ziemniak Witold, Majka Jolanta, Hahn Eckhart G, Konturek Stanislaw J

机构信息

Department of Physiology, Jagellonian University College of Medicine, Cracow, Poland.

出版信息

Dig Dis Sci. 2002 May;47(5):978-86. doi: 10.1023/a:1015017502772.

DOI:10.1023/a:1015017502772
PMID:12018924
Abstract

Helicobacter pylori (Hp) is a common pathogen colonizing the a gastric mucosa, but some reports indicated that it may also be found in the oral cavity, which could serve as a reservoir of the bacteria and a source of gastric reinfection. Accordingly, we aimed to study whether the oral cavity, particularly gingival pockets, are colonized by Hp and whether it could be the source of gastric reinfection. We studied 329 patients with dyspeptic symptoms (257 with chronic gastritis, 15 with gastric ulcer, and 57 with duodenal ulcer). The [13C]urea breath test (UBT), gastroscopy, and Hp culture from gastric biopsies were carried out, and material was collected from the oral cavity (gingival pocket) for bacteriological culture and genomic DNA studies. The serum was obtained for anti-Hp IgG and anti-CagA assays and saliva for anti-Hp IgA determination using the ELISA technique. Bacteria in material from gingival pockets and biopsies from the corpus and antrum of stomach of 30 DU patients before and after Hp eradication were also examined by PCR technique, using primers specific for 16S rRNA. All Hp-positive patients (276) were subjected to one week of triple therapy (omeprazole 2 x 20 mg twice a day, clarithromycin 2 x 500 mg twice a day, and metronidazole 2 x 500 mg twice a day). The measurements described above were then repeated at four weeks and six months. Bacteriological culture showed the presence of Hp in the material from oral cavity in about 50% of patients, whereas UBT, used as a gold standard, revealed gastric Hp infection in about 84% of these patients. The eradication was successful in the majority of patients (87%), but about 13% of them were still Hp positive after four weeks and about 21% after six months. Four weeks after Hp therapy, Hp was found in culture from oral samples in 23% (P < 0.05 vs initial) and after six months in 35.1%. The IgA levels recorded in saliva were in a close agreement with UBT results. Hp DNA assessed by PCR in 30 DUs before eradication of Hp was detected in 95% of antral mucosa, 90% in corpus mucosa, and in 35% of gingival pocket material, and after eradication therapy Hp DNA values fell to 25%, 20%, and 10%, respectively. In conclusion, Hp is commonly detected in the oral cavity of patients with dyspeptic symptoms, but the gastric reinfection does not appear to occur in the patients despite oral Hp colonization.

摘要

幽门螺杆菌(Hp)是一种定植于胃黏膜的常见病原体,但一些报告表明,在口腔中也可能发现它,口腔可能是该细菌的储存库和胃部再次感染的来源。因此,我们旨在研究口腔,特别是牙龈沟,是否被Hp定植,以及它是否可能是胃部再次感染的来源。我们研究了329例有消化不良症状的患者(257例慢性胃炎患者、15例胃溃疡患者和57例十二指肠溃疡患者)。进行了[13C]尿素呼气试验(UBT)、胃镜检查以及胃活检组织的Hp培养,并从口腔(牙龈沟)采集材料进行细菌培养和基因组DNA研究。采集血清用于抗Hp IgG和抗CagA检测,采集唾液用于采用ELISA技术测定抗Hp IgA。还采用针对16S rRNA的引物,通过PCR技术检测了30例十二指肠溃疡患者在根除Hp前后牙龈沟材料和胃体及胃窦活检组织中的细菌。所有Hp阳性患者(276例)接受了为期一周的三联疗法(奥美拉唑2×20mg,每日2次;克拉霉素2×500mg,每日2次;甲硝唑2×500mg,每日2次)。然后在4周和6个月时重复上述测量。细菌培养显示,约50%的患者口腔材料中存在Hp,而作为金标准的UBT显示,这些患者中约84%存在胃部Hp感染。大多数患者(87%)根除成功,但约13%的患者在4周后仍为Hp阳性,6个月后约21%仍为阳性。Hp治疗4周后,23%的口腔样本培养中发现Hp(与初始相比P<0.05),6个月后为3

相似文献

1
Oral cavity as a potential source of gastric reinfection by Helicobacter pylori.口腔作为幽门螺杆菌导致胃部再次感染的潜在来源。
Dig Dis Sci. 2002 May;47(5):978-86. doi: 10.1023/a:1015017502772.
2
Oral cavity as permanent reservoir of Helicobacter pylori and potential source of reinfection.口腔作为幽门螺杆菌的持久储存库及再感染的潜在来源。
J Physiol Pharmacol. 1996 Mar;47(1):121-9.
3
Implications of oral Helicobacter pylori for the outcome of its gastric eradication therapy.口腔幽门螺杆菌对其胃根除治疗结果的影响。
J Clin Gastroenterol. 2007 Feb;41(2):145-51. doi: 10.1097/01.mcg.0000225654.85060.3d.
4
The link between Helicobacter pylori infection and rosacea.幽门螺杆菌感染与酒渣鼻之间的关联。
J Eur Acad Dermatol Venereol. 2002 Jul;16(4):328-33. doi: 10.1046/j.1468-3083.2002.00497.x.
5
Association of the presence of Helicobacter pylori in the oral cavity and in the stomach.口腔与胃中幽门螺杆菌存在情况的关联
J Physiol Pharmacol. 2004 Jul;55 Suppl 2:105-15.
6
Helicobacter pylori in the oral cavity and its implications for gastric infection, periodontal health, immunology and dyspepsia.口腔中的幽门螺杆菌及其对胃部感染、牙周健康、免疫学和消化不良的影响。
J Physiol Pharmacol. 2005 Dec;56 Suppl 6:77-89.
7
Gene expression of ornithine decarboxylase, cyclooxygenase-2, and gastrin in atrophic gastric mucosa infected with Helicobacter pylori before and after eradication therapy.根除治疗前后幽门螺杆菌感染的萎缩性胃黏膜中鸟氨酸脱羧酶、环氧化酶-2和胃泌素的基因表达
Dig Dis Sci. 2003 Jan;48(1):36-46. doi: 10.1023/a:1021774029089.
8
Patients with dyspepsia benefit from eradication of Helicobacter pylori if other organic causes for dyspepsia were carefully ruled out.如果仔细排除了其他导致消化不良的器质性病因,消化不良患者可从根除幽门螺杆菌中获益。
Z Gastroenterol. 2000 Mar;38(3):211-9. doi: 10.1055/s-2000-14860.
9
Helicobacter pylori and its eradication in rosacea.幽门螺杆菌及其在酒渣鼻治疗中的根除
J Physiol Pharmacol. 1999 Dec;50(5):777-86.
10
[The clinical significance of GastroPanel in diagnostics of Helicobacter pylori eradication efficiency in patients with dyspepsia with correlation of family history of gastric cancer].[胃功能检测组合(GastroPanel)在消化不良患者幽门螺杆菌根除疗效诊断中的临床意义及与胃癌家族史的相关性]
Pol Merkur Lekarski. 2013 Sep;35(207):141-7.

引用本文的文献

1
Genome of and Serotype of HPV Detected in Oropharyngeal and Laryngeal Cancer and Chronic Inflammation Patients.口咽癌和喉癌及慢性炎症患者中 HPV 的基因组和血清型。
Int J Environ Res Public Health. 2021 Sep 10;18(18):9545. doi: 10.3390/ijerph18189545.
2
Long-term follow-up of reinfection and its risk factors after initial eradication: a large-scale multicentre, prospective open cohort, observational study.初始根除后再感染及其危险因素的长期随访:一项大规模多中心、前瞻性开放队列、观察性研究。
Emerg Microbes Infect. 2020 Mar 11;9(1):548-557. doi: 10.1080/22221751.2020.1737579. eCollection 2020.
3
An association between Helicobacter pylori and upper respiratory tract disease: fact or fiction?

本文引用的文献

1
Helicobacter pylori-gastrin link in MALT lymphoma.胃黏膜相关淋巴组织淋巴瘤中幽门螺杆菌与胃泌素的联系
Aliment Pharmacol Ther. 2000 Oct;14(10):1311-8. doi: 10.1046/j.1365-2036.2000.00832.x.
2
Activation of genes for superoxide dismutase, interleukin-1beta, tumor necrosis factor-alpha, and intercellular adhesion molecule-1 during healing of ischemia-reperfusion-induced gastric injury.缺血再灌注诱导的胃损伤愈合过程中超氧化物歧化酶、白细胞介素-1β、肿瘤坏死因子-α和细胞间黏附分子-1基因的激活。
Scand J Gastroenterol. 2000 May;35(5):452-63. doi: 10.1080/003655200750023697.
3
Role of gastrin in gastric cancerogenesis in Helicobacter pylori infected humans.
幽门螺杆菌与上呼吸道疾病之间的关联:事实还是虚构?
World J Gastroenterol. 2014 Feb 14;20(6):1470-84. doi: 10.3748/wjg.v20.i6.1470.
4
Long-term follow up Helicobacter Pylori reinfection rate after second-line treatment: bismuth-containing quadruple therapy versus moxifloxacin-based triple therapy.二线治疗后幽门螺杆菌再感染的长期随访:含铋四联疗法与基于莫西沙星的三联疗法。
BMC Gastroenterol. 2013 Sep 19;13:138. doi: 10.1186/1471-230X-13-138.
5
Detection of Helicobacter pylori in oropharyngeal lymphatic tissue with real-time PCR and assessment of its carcinogenic potential.实时聚合酶链反应检测口咽淋巴组织中的幽门螺杆菌及其致癌潜能评估。
Eur Arch Otorhinolaryngol. 2014 Feb;271(2):399-405. doi: 10.1007/s00405-013-2574-1. Epub 2013 Jun 7.
6
Saliva secretion and efficacy of helicobacter pylori eradication in peptic ulcer patients.消化性溃疡患者的唾液分泌与幽门螺杆菌根除疗效
J Dent (Tehran). 2011 Fall;8(4):165-9. Epub 2011 Dec 20.
7
Reinfection rate of Helicobacter pylori after eradication treatment: a long-term prospective study in Japan.幽门螺杆菌根除治疗后的再感染率:日本的一项长期前瞻性研究。
J Gastroenterol. 2012 Jun;47(6):641-6. doi: 10.1007/s00535-012-0536-9. Epub 2012 Feb 17.
8
Optimal therapy for Helicobacter pylori infections.幽门螺杆菌感染的最佳治疗方法。
Nat Rev Gastroenterol Hepatol. 2011 Feb;8(2):79-88. doi: 10.1038/nrgastro.2010.210.
9
H pylori recurrence after successful eradication.幽门螺杆菌成功根除后的复发情况。
World J Gastroenterol. 2008 Mar 14;14(10):1477-8. doi: 10.3748/wjg.14.1477.
胃泌素在幽门螺杆菌感染人群胃癌发生中的作用。
J Physiol Pharmacol. 1999 Dec;50(5):857-73.
4
Association of Helicobacter pylori infection with coronary heart disease.幽门螺杆菌感染与冠心病的关联
J Physiol Pharmacol. 1999 Dec;50(5):743-51.
5
Epidemiological study on Helicobacter pylori infection and extragastroduodenal disorders in Polish population.波兰人群幽门螺杆菌感染与胃十二指肠外疾病的流行病学研究。
J Physiol Pharmacol. 1999 Dec;50(5):723-33.
6
Helicobacter pylori in the oral cavity reflects handling of contaminants but not gastric infection.口腔中的幽门螺杆菌反映了污染物的处理情况,而非胃部感染。
Digestion. 1999;60(3):196-202. doi: 10.1159/000007659.
7
Evaluation of Pyloriset Screen, a rapid whole-blood diagnostic test for Helicobacter pylori infection.幽门螺杆菌感染快速全血诊断检测Pyloriset Screen的评估
J Clin Microbiol. 1998 Apr;36(4):955-7. doi: 10.1128/JCM.36.4.955-957.1998.
8
Detection of Helicobacter pylori in various oral lesions by nested polymerase chain reaction (PCR).通过巢式聚合酶链反应(PCR)检测各种口腔病变中的幽门螺杆菌。
J Oral Pathol Med. 1998 Jan;27(1):1-3. doi: 10.1111/j.1600-0714.1998.tb02081.x.
9
The role of the oral cavity in Helicobacter pylori infection.口腔在幽门螺杆菌感染中的作用。
Am J Gastroenterol. 1997 Dec;92(12):2148-54.
10
Helicobacter pylori in gastro-oesophageal reflux disease: causal agent, independent or protective factor?胃食管反流病中的幽门螺杆菌:致病因子、独立因素还是保护因素?
Gut. 1997 Sep;41(3):277-80. doi: 10.1136/gut.41.3.277.